inHEART Medical, an international healthcare company with offices in France and the United States, has received clearance from the U.S. Food and Drug Administration (FDA) for its new 3D visualization software designed to improve the management of ventricular tachycardia (VT) ablation and other cardiac ablation procedures in the electrophysiology…
The 65-year-old male patient presented with a long medical history and many comorbidities, making surgery too risky and transcaval access was the best path forward.
Ask Bio, acquired by Bayer for more than $2 billion in 2020, is enrolling patients for a new clinical trial focused on the therapy’s effectiveness in…
Stroke is typically seen as the biggest danger for patients after they receive an AFib diagnosis. This study, however, suggests heart failure could be an…
The 65-year-old male patient presented with a long medical history and many comorbidities, making surgery too risky and transcaval access was the best path forward.
How have recent FDA approvals for Edwards Lifesciences and Abbott changed patient care? Andrew Rassi, MD, answered that question—and many more—in a new interview.
The new gene therapy candidate is now one step closer to being approved by the FDA.
There have been a total of 11 incidents so far, including seven injuries and two deaths. Boston Scientific said the agent can still be used…
Biga, who originally trained as a nurse, specializes in the business side of cardiology. She also emphasized the increasing importance of AI and other new…
Finding new ways to avoid intraoperative anemia could go a long way toward improving outcomes for female CABG patients. The full analysis, based on more than…
“CT-FFR makes the CT ‘better’, but we found that the benefits were highest when used selectively,” one radiologist explained.
